Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Moodys
Mallinckrodt
Baxter
Johnson and Johnson

Last Updated: October 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Lersivirine

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Lersivirine: Patents, clinical trial progress, indications

Lersivirine is an investigational drug.

There have been 9 clinical trials for Lersivirine. The most recent clinical trial was a Phase 1 trial, which was initiated on July 1st 2009.

The most common disease condition in clinical trials is [disabled in preview]. The leading clinical trial sponsors are Pfizer, ViiV Healthcare, and [disabled in preview].

Recent Clinical Trials for Lersivirine
TitleSponsorPhase
Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-release Lersivirine 500 mg in Healthy SubjectsViiV HealthcarePhase 1
Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-release Lersivirine 500 mg in Healthy SubjectsPfizerPhase 1
A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022ViiV HealthcarePhase 2

See all Lersivirine clinical trials

Clinical Trial Summary for Lersivirine

Top disease conditions for Lersivirine
Top clinical trial sponsors for Lersivirine

See all Lersivirine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Johnson and Johnson
Colorcon
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.